BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-517@pharmaconomics
DTSTAMP:20260707T034628Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:PRAX Phase 3 — elsunersen (estimated date)
DESCRIPTION:Phase 3 trial results for elsunersen in early-seizure-onset SCN2A DEE are due ~ Dec 31\, 2027. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000028/praxisye2025pr.htm\n\nTrack it: https://www.pharmaconomics.com/e/517
URL:https://www.pharmaconomics.com/e/517
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PRAX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR